MedPage Today on MSN
GLP-1s Tied to Big Survival Advantage in Colon Cancer Patients
In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...
News-Medical.Net on MSN
VR raises eye temperature and thickens protective tear layer
VR gaming impacts tear film dynamics, increasing lipid layer thickness and eye temperature, but fails to enhance tear ...
The University of the Western Cape has started a male fetility drive that aims to deepen understanding of male reproductive health and sperm function in South African men.
In a clinic north of Baltimore, Myriam Lucia Vega Gonzalez meets patients every day of the week who have all types of hair ...
News-Medical.Net on MSN
Understanding leptin's dual function in MAFLD pathogenesis
Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a predominant chronic liver condition globally, ...
FDA has approved Komzifti (ziftomenib) as the first once-daily, oral menin inhibitor for adults with relapsed or refractory NPM1-mutated AML, supported by Phase II KOMET-001 data showing meaningful ...
Study Finds on MSN
Probiotics Won’t Cure Autism. Here’s Why The Science Doesn’t Add Up
Gut bacteria doesn’t appear to cause autism. The relationship may run in the opposite direction: Autistic eating patterns ...
GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...
The physics of mixing water layers — an interplay of wind, climate and more — makes lakes work. When it stops, impacts can ...
When leadership divests their holdings on such a scale, especially during a period of operational strength, it sends a powerful message: a lack of confidence in the current valuation. Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results